Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma

Figure 1 Expression levels of brain cytoplasmic RNA1 in pan-cancer and hepatocellular carcinoma. A: Expression level of brain cytoplasmic RNA1 (BCYRN1) in pan-carcinoma; B: Differential analysis of expression of BCYRN1 in hepatocellular carcinoma (HCC) tissues compared with normal liver tissues based on the Cancer Genome Atlas database; C: Pairwise difference analysis of BCYRN1 expression between HCC tissues and surrounding normal liver tissues from the same patient. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001, ^dP < 0.0001.